TNF-α and IL-1β Do Not Induce Langerhans Cell Migration by Inhibiting TGFβ Activation

JID Innov. 2021 May 24;1(3):100028. doi: 10.1016/j.xjidi.2021.100028. eCollection 2021 Sep.

Abstract

In the skin, Langerhans cells (LCs) require autocrine latent TGFβ that is transactivated by the integrins ανβ6 and ανβ8 expressed by keratinocytes (KCs) for long-term epidermal retention. Selective expression of a ligand-independent, constitutively active form of TGFβR1 inhibits LC migration during homeostasis and in response to UVB exposure. In this study, we found that LC migration in response to inflammatory stimuli was also inhibited by ligand-independent TGFβR1 signaling. Contrary to UVB stimulation, which reduced KC expression of ανβ6, in vitro and in vivo exposure to TNF-α or IL-1β increased ανβ6 transcript and protein expression by KCs. This resulted in increased KC-mediated transactivation of latent TGFβ. Expression of ανβ8 was largely unchanged. These findings show that ligand-independent TGFβR1 signaling in LCs can overcome inflammatory migration stimuli, but reduced KC-mediated transactivation of latent TGFβ by KCs may only drive LC migration during homeostasis and in response to UV stimulation.

Keywords: DMBA, 7,12-dimethylbenz[a]anthracene; EpCAM, epithelial cell adhesion molecule; IFE, interfollicular; IM, infundibulum/isthmus; KC, keratinocyte; LAP, latency associated peptide; LC, Langerhans cell; LN, lymph node; MHC, major histocompatibility complex; pKC, primary keratinocyte.